Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.

[1]  Scott Montgomery,et al.  Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. , 2017, Blood.

[2]  B. Burkhardt,et al.  The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis. , 2016, Blood.

[3]  L. Luzzatto,et al.  Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry , 2016, The Journal of allergy and clinical immunology.

[4]  W. Ferlin,et al.  A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLH , 2015 .

[5]  A. Schram,et al.  How I treat hemophagocytic lymphohistiocytosis in the adult patient. , 2015, Blood.

[6]  T. Torgerson,et al.  Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  S. Davies,et al.  Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  C. Allen,et al.  fHLH: becoming a blended family. , 2014, Blood.

[9]  C. Cancrini,et al.  HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. , 2014, Blood.

[10]  V. Cetica,et al.  Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning , 2014, Front. Immunol..

[11]  A. Schulz,et al.  Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis , 2014, Haematologica.

[12]  G. Janka,et al.  Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. , 2013, Hematology. American Society of Hematology. Education Program.

[13]  K. Myers,et al.  An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  K. Kawa,et al.  Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan , 2013, International Journal of Hematology.

[15]  T. Schechter,et al.  Increased complications and morbidity in children with hemophagocytic lymphohistiocytosis undergoing hematopoietic stem cell transplantation , 2013, Clinical transplantation.

[16]  R. Egeler,et al.  Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. , 2011, Blood.

[17]  S. Davies,et al.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. , 2010, Blood.

[18]  H. Koo,et al.  The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis , 2010, Pediatric transplantation.

[19]  F. Aversa,et al.  Regression modeling of competing risk using R: an in depth guide for clinicians , 2010, Bone Marrow Transplantation.

[20]  T. Hara,et al.  Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in Japan , 2010, Pediatric blood & cancer.

[21]  W. Friedrich,et al.  Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation , 2009, Bone Marrow Transplantation.

[22]  E. Lanino,et al.  Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP) , 2008, Haematologica.

[23]  P. Veys,et al.  The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis , 2008, Bone Marrow Transplantation.

[24]  W. Grossman,et al.  Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis , 2008, Bone Marrow Transplantation.

[25]  F. Aversa,et al.  Competing risk analysis using R: an easy guide for clinicians , 2007, Bone Marrow Transplantation.

[26]  M. Aricò,et al.  HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.

[27]  A. Fischer,et al.  Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Single-Center Report of 48 Patients , 2006, Pediatrics.

[28]  P. Veys,et al.  Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. , 2006, Blood.

[29]  F. Locatelli,et al.  Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis , 2005, British journal of haematology.

[30]  R. Egeler,et al.  Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. , 2002, Blood.

[31]  N. Kröger,et al.  Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single‐centre experience of 12 patients , 1999, British journal of haematology.

[32]  M. Steinbuch,et al.  Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. , 1997, Blood.

[33]  G. Leverger,et al.  Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. , 1986, The Journal of pediatrics.

[34]  H. Deeg,et al.  Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. , 1983, Annals of internal medicine.

[35]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.